About: CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. The company develops leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. Its leronlimab completed phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.25 (+4.13%)
CYDY NYSE Cytodyn Inc
Cytodyn Inc share price
CYDY price activity
Last Price
$0.250
Change (24hr)
0.01 USD (6.16%)
Volume
976.73K
Volume (4w avg)
-
Open
$0.24
Day Range
$0.24 - $0.25
Previous Close
$0.24
Last Trade
13 Nov, 7:54 pm GMT+0
Delayed
13 Nov, 7:54 pm GMT+0
CYDY price performance
Delayed
13 Nov, 7:54 pm GMT+0
CYDY details
CYDY Market Signals